Ironwood Pharmaceuticals Statistics Share Statistics Ironwood Pharmaceuticals has 161.82M
shares outstanding. The number of shares has increased by 1.3%
in one year.
Shares Outstanding 161.82M Shares Change (YoY) 1.3% Shares Change (QoQ) 1.12% Owned by Institutions (%) 86.47% Shares Floating 155.76M Failed to Deliver (FTD) Shares 37,849 FTD / Avg. Volume 1.69%
Short Selling Information The latest short interest is 6.53M, so 4.03% of the outstanding
shares have been sold short.
Short Interest 6.53M Short % of Shares Out 4.03% Short % of Float 6.13% Short Ratio (days to cover) 5.24
Valuation Ratios The PE ratio is 800.84 and the forward
PE ratio is 2.66.
Ironwood Pharmaceuticals's PEG ratio is
-8.
PE Ratio 800.84 Forward PE 2.66 PS Ratio 2.01 Forward PS 0.5 PB Ratio -2.34 P/FCF Ratio 6.82 PEG Ratio -8
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Ironwood Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.69,
with a Debt / Equity ratio of -1.99.
Current Ratio 4.69 Quick Ratio 4.69 Debt / Equity -1.99 Debt / EBITDA 5.98 Debt / FCF 5.8 Interest Coverage 2.82
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $1.39M Profits Per Employee $3.48K Employee Count 253 Asset Turnover 1 Inventory Turnover n/a
Taxes Income Tax 64.32M Effective Tax Rate 98.65%
Stock Price Statistics The stock price has increased by -80.19% in the
last 52 weeks. The beta is 0.33, so Ironwood Pharmaceuticals's
price volatility has been higher than the market average.
Beta 0.33 52-Week Price Change -80.19% 50-Day Moving Average 0.73 200-Day Moving Average 2.07 Relative Strength Index (RSI) 60.65 Average Volume (20 Days) 2,239,264
Income Statement In the last 12 months, Ironwood Pharmaceuticals had revenue of 351.41M
and earned 880K
in profits. Earnings per share was 0.01.
Revenue 351.41M Gross Profit 351.41M Operating Income 93.12M Net Income 880K EBITDA 100.24M EBIT 98.23M Earnings Per Share (EPS) 0.01
Full Income Statement Balance Sheet The company has 88.56M in cash and 599.48M in
debt, giving a net cash position of -510.92M.
Cash & Cash Equivalents 88.56M Total Debt 599.48M Net Cash -510.92M Retained Earnings -1.7B Total Assets 327.21M Working Capital 112.48M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 103.55M
and capital expenditures -142K, giving a free cash flow of 103.41M.
Operating Cash Flow 103.55M Capital Expenditures -142K Free Cash Flow 103.41M FCF Per Share 0.65
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of 26.5% and 0.25%.
Gross Margin 100% Operating Margin 26.5% Pretax Margin 18.55% Profit Margin 0.25% EBITDA Margin 28.53% EBIT Margin 26.5% FCF Margin 29.43%
Dividends & Yields IRWD does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for IRWD is $1,
which is 19% higher than the current price. The consensus rating is "Hold".
Price Target $1 Price Target Difference 19% Analyst Consensus Hold Analyst Count 5
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $0.05 Lynch Upside -94.05% Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Apr 2, 2019. It was a
forward
split with a ratio of 597:500.
Last Split Date Apr 2, 2019 Split Type forward Split Ratio 597:500
Scores Altman Z-Score -5.33 Piotroski F-Score 5
